Lipidation and PEGylation strategies to prolong the in vivo half-life of a nanomolar EphA4 receptor antagonist
Maricel Gómez‐Soler(Sanford Burnham Prebys Medical Discovery Institute), Elena B. Pasquale(Discovery Institute)
Cited by 3
Related Papers
Eph Receptors and Ephrins: Therapeutic Opportunities
|The Annual Review of Pharmacology and Toxicology|2014|312
Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling
|Journal of Biological Chemistry|2019|65
Regulation of the EphA2 receptor intracellular region by phosphomimetic negative charges in the kinase-SAM linker
|Nature Communications|2021|30
The Src Homology 2 Domain Protein Shep1 Plays an Important Role in the Penetration of Olfactory Sensory Axons into the Forebrain
|Journal of Neuroscience|2010|15
A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain
|Journal of Biological Chemistry|2021|14